AcrySof™ IQ PanOptix™ Toric UV IOL TFAT30 (REF TFAT30.165)Recalls & reported problems
Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant
All models of AcrySof IQ PanOptix Toric UV IOL (120)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00380652418638), received between Apr 23, 2021 and May 1, 2024 — classified as 6 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem6
Patient problems
- Visual Impairment4
- Blurred Vision2
- Halo2
- Insufficient Information1
- Visual Disturbances1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryMay 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED VA FLUX, CLOUDY VA, UNCLEAR AND CLINICAL REASON FOR EXPLANT BEING SUBJECTIVE VISUAL DISTURBANCE. THE IOL WAS EXPLANTED AND EXCHANGED FOR AN UNKNOWN ATIOL FOLLOWING THE INITIAL IMPLANT PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING THAT PT UNDERWENT A YAG IN JAN 2023 AND THE LASIK MARCH OF 2023 IN THE LEFT EYE AFTER THE INITIAL IMPLANT. THESE PROCEDURES WERE DONE TO SEE IF THEY WOULD ALLEVIATE PATIENTS COMPLAINTS WITH HER LEFT EYE, AFTER MUCH CONSIDERATION, IT WAS AGREED UPON THAT AN IOL EXCHANGE TO A MONOFOCAL IOL WAS HER BEST OPTION. IN THE SURGEON'S OPINION WHAT CAUSED THE EVENT WAS SUBJECTIVE VISUAL CONCERNS, PATIENTS VISUAL ACUITY WAS GREAT, SHE JUST COULDN'T ADJUST TO THE MODALITY OF THE MULTIFOCAL. LENS WAS EXCHANGED WITH A NON COMPANY LENS. SYMPTOMS RESOLVED. SURGEON'S PROGNOSIS WAS, SO FAR SHE'S ONLY BEEN SEEN ON 4/3 FOR THE 1 DAY POST OP, HEALING WELL, BUT NOT ENOUGH INFO YET.
Patient problems: Visual Impairment
MAUDE report 19221980 ↗InjuryMay 22, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED GLARE, HALOS AND NO CONTRAST . THE IOL WAS EXCHANGED FOR ANOTHER LENS MODEL 18 MONTHS FOLLOWING THE INITIAL IMPLANT PROCEDURE. THE CLINICAL REASON FOR EXPLANT MENTIONED AS UNACCEPTABLE QUALITY OF VISION DUE TO GLARE, HALOS, NO CONTRAST . ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Patient problems: Halo; Visual Disturbances; Visual Impairment
MAUDE report 16972557 ↗InjuryMar 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON-HEALTHCARE PROFESSIONAL REPORTED FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT COMPLAINED OF VISION UNCLEAR AT ALL RANGES AND CAN¿T READ. THE LENS WAS EXPLANTED AND REPLACED WITH ANOTHER LENS IN A SECONDARY PROCEDURE. THERE WAS NO PATIENT HARM AND PATIENT WAS NOT HOSPITALIZED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS REQUESTED, BUT FURTHER NO INFORMATION WAS AVAILABLE.
Patient problems: Blurred Vision
MAUDE report 16476270 ↗InjuryJul 12, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A FACILITY REPRESENTATIVE REPORTED THAT 50 DAYS FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE IOL WAS EXCHANGED FOR ANOTHER LENS DUE TO A REFRACTIVE ERROR AND NOT ABLE TO SEE WELL.
Patient problems: Visual Impairment
MAUDE report 12148651 ↗InjuryMay 7, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PHYSICIAN REPORTED AN EXPLANTED INTRAOCULAR LENS FOR A PATIENT. ADDITIONAL INFORMATION WAS RECEIVED REPORTING THAT IN THE SURGEON¿S OPINION, THE PRODUCT CAUSE OR CONTRIBUTE TO THE EVENT.
Patient problems: Insufficient Information
MAUDE report 11789674 ↗InjuryApr 23, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CUSTOMER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRY VISION, GLARE AND HALOS. DESCRIBED VISION AS "LIKE LOOKING THROUGH A BOTTLE". THE IOL WAS EXCHANGED FOR ANOTHER LENS APPROXIMATELY TWO MONTHS AFTER THE INITIAL IMPLANTATION. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Patient problems: Blurred Vision; Halo; Visual Impairment
MAUDE report 11712790 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page